While not evaluated in patients undergoing chemotherapy, in a study of men with prostate cancer,43 compared to nonfatigued controls, TRAIL cytokine expression and mrna expression of TRAILR were upregulated in fatigued patients. Here, TNFSF10 is linked to prostate carcinoma.